These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Deedwania PC. Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743 [Abstract] [Full Text] [Related]
9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G, BENEDICT Study Group. J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240 [Abstract] [Full Text] [Related]
10. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM. Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [Abstract] [Full Text] [Related]
11. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients]. Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X. Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025 [Abstract] [Full Text] [Related]
12. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G. Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [Abstract] [Full Text] [Related]
13. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL. Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [Abstract] [Full Text] [Related]
14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K. Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [Abstract] [Full Text] [Related]
17. Improvement of blood pressure control in a hypertension clinic in Japan: a 15-year follow-up study. Ohta Y, Matsumura K, Tsuchihashi T, Ohtsubo T, Arima H, Miwa Y, Goto K, Ohya Y, Fujii K, Uezono K, Abe I, Iida M. Clin Exp Hypertens; 2009 Oct; 31(7):553-9. PubMed ID: 19886853 [Abstract] [Full Text] [Related]
18. Antihypertensive medication changes and blood pressure goal achievement in a managed care population. Engel-Nitz NM, Darkow T, Lau H. J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489 [Abstract] [Full Text] [Related]
19. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study. Bajraktari G, Sylejmani X, Thaçi K, Elezi S, Ndrepepa G. Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050 [Abstract] [Full Text] [Related]